CYTOTHERAPY

metrics 2024

Elevating Research in Cell Therapy and Transplantation.

Introduction

CYTOTHERAPY is a distinguished journal published by Elsevier Science Ltd, focusing on the critical fields of cell therapy, transplantation, and regenerative medicine. Since its inception in 1999, the journal has established itself as a vital resource for researchers and practitioners, contributing significantly to advancements in Cancer Research, Cell Biology, Genetics, Immunology, and Oncology. With an impressive range of Q2 rankings across multiple categories and a remarkable Q1 standing in Transplantation for 2023, CYTOTHERAPY delivers high-impact research that addresses the evolving challenges in these fields. While the journal does not offer open access, it remains a reputable avenue for disseminating pivotal studies and reviews that push the boundaries of cell-based therapies. Researchers, clinicians, and students alike will find CYTOTHERAPY an indispensable platform to stay abreast of the latest discoveries and innovations that are shaping the future of medical science.

Metrics 2024

SCIMAGO Journal Rank1.08
Journal Impact Factor3.70
Journal Impact Factor (5 years)4.30
H-Index105
Journal IF Without Self3.70
Eigen Factor0.00
Normal Eigen Factor1.01
Influence1.02
Immediacy Index1.30
Cited Half Life8.10
Citing Half Life6.80
JCI0.81
Total Documents2733
WOS Total Citations6945
SCIMAGO Total Citations25285
SCIMAGO SELF Citations1448
Scopus Journal Rank1.08
Cites / Document (2 Years)3.60
Cites / Document (3 Years)3.63
Cites / Document (4 Years)3.97

Metrics History

Rank 2024

Scopus

Transplantation in Medicine
Rank #14/54
Percentile 74.07
Quartile Q2
Oncology in Medicine
Rank #116/404
Percentile 71.29
Quartile Q2
Genetics (clinical) in Medicine
Rank #35/99
Percentile 64.65
Quartile Q2
Immunology and Allergy in Medicine
Rank #91/233
Percentile 60.94
Quartile Q2
Cancer Research in Biochemistry, Genetics and Molecular Biology
Rank #96/230
Percentile 58.26
Quartile Q2
Immunology in Immunology and Microbiology
Rank #108/236
Percentile 54.24
Quartile Q2
Cell Biology in Biochemistry, Genetics and Molecular Biology
Rank #151/285
Percentile 47.02
Quartile Q3

IF (Web Of Science)

BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Rank 54/174
Percentile 69.30
Quartile Q2
CELL & TISSUE ENGINEERING
Rank 15/31
Percentile 53.20
Quartile Q2
CELL BIOLOGY
Rank 99/205
Percentile 52.00
Quartile Q2
HEMATOLOGY
Rank 23/97
Percentile 76.80
Quartile Q1
MEDICINE, RESEARCH & EXPERIMENTAL
Rank 69/189
Percentile 63.80
Quartile Q2

JCI (Web Of Science)

BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Rank 60/174
Percentile 65.52
Quartile Q2
CELL & TISSUE ENGINEERING
Rank 14/31
Percentile 54.84
Quartile Q2
CELL BIOLOGY
Rank 81/205
Percentile 60.49
Quartile Q2
HEMATOLOGY
Rank 30/97
Percentile 69.07
Quartile Q2
MEDICINE, RESEARCH & EXPERIMENTAL
Rank 68/189
Percentile 64.02
Quartile Q2

Quartile History

Similar Journals

Cell Journal

Bridging Disciplines in Cell and Molecular Biology
Publisher: ROYAN INSTISSN: 2228-5806Frequency: 12 issues/year

Cell Journal is a leading interdisciplinary publication in the fields of Cell Biology, Developmental Biology, Molecular Biology, and Reproductive Medicine, published by ROYAN INST since its inception as an open-access journal in 2007. With an ISSN of 2228-5806 for print and 2228-5814 for electronic editions, it provides a vital platform for researchers and professionals to disseminate innovative findings and insights that shape our understanding of cellular processes and reproductive sciences. The journal boasts an impressive Scopus ranking, achieving a Q3 position in both Molecular Biology and Reproductive Medicine, highlighting its significance in the academic community. Situated in Tehran, Iran, Cell Journal encourages global collaboration through its accessible content, making cutting-edge research available to a diverse audience. As it converges from 2011 to 2024, the journal continues to emphasize the importance of thorough scientific inquiry, fostering advancements that drive both theoretical frameworks and practical applications in cell science.

CELL RESEARCH

Elevating Insights in Cell and Molecular Sciences
Publisher: SPRINGERNATUREISSN: 1001-0602Frequency: 12 issues/year

CELL RESEARCH is a premier peer-reviewed journal dedicated to advancing the field of cell biology and molecular biology, published by SpringerNature. With an impressive impact factor and consistently ranking in the Q1 quartile for both cell biology and molecular biology, this journal serves as a pivotal resource for researchers, professionals, and students seeking to explore the latest discoveries and advancements in cellular mechanisms and their implications for health and disease. Since its inception in 1996, CELL RESEARCH has cultivated a distinguished reputation, currently boasting ranks in the top percentile of Scopus categories, reaffirming its influence and relevance to the scientific community. Although it is not an Open Access journal, its rigorous selection process ensures the publication of high-quality articles that contribute significantly to our understanding of life sciences. For those deeply engaged in the realms of biochemistry, genetics, and molecular biology, CELL RESEARCH is an essential conduit of innovative research and critical insights.

STEM CELLS AND DEVELOPMENT

Transforming Insights into Impactful Solutions
Publisher: MARY ANN LIEBERT, INCISSN: 1547-3287Frequency: 24 issues/year

STEM CELLS AND DEVELOPMENT, published by Mary Ann Liebert, Inc., is a leading peer-reviewed journal dedicated to the rapidly advancing fields of stem cell biology and developmental science. With an ISSN of 1547-3287 and an E-ISSN of 1557-8534, the journal encompasses a broad range of topics central to understanding stem cells' roles in development and regeneration processes. It holds a prestigious standing within its category quartiles, ranking Q3 in Cell Biology, Q2 in Developmental Biology, and Q2 in Hematology for 2023. With its convergence from 2004 to 2024, STEM CELLS AND DEVELOPMENT fosters an innovative platform for researchers, professionals, and students to disseminate groundbreaking research, share insights, and explore novel therapeutic approaches. Open access options enhance the journal's visibility and accessibility, promoting a collaborative exchange of information among the scientific community. Positioned at the forefront of stem cell research and its applications, this journal is vital for anyone seeking to stay informed about the latest advancements and trends within these critical areas of study.

Stem Cell Research & Therapy

Empowering Innovation in Stem Cell Science
Publisher: BMCISSN: Frequency: 1 issue/year

Stem Cell Research & Therapy is an esteemed international journal published by BMC, specializing in the rapidly advancing fields of stem cell research and regenerative therapies. Since its inception in 2010, the journal has embraced an Open Access model, ensuring that vital research is readily accessible to a global audience. With a significant impact in the scientific community, it holds Q1 quartile rankings in prestigious categories such as Biochemistry, Genetics and Molecular Biology, Cell Biology, and Molecular Medicine, highlighting its critical role in promoting groundbreaking research. The journal’s high Scopus rankings—placing it in the top echelons of its fields—reflect its commitment to publishing high-quality, peer-reviewed studies that advance our understanding of stem cell biology and therapeutic applications. Aimed at researchers, healthcare professionals, and students alike, Stem Cell Research & Therapy is an indispensable resource for those dedicated to the exploration and innovation within this transformative area of science.

CANCER GENE THERAPY

Shaping the Future of Cancer Research and Therapy
Publisher: SPRINGERNATUREISSN: 0929-1903Frequency: 12 issues/year

Cancer Gene Therapy, published by SpringerNature, stands at the forefront of research in the fields of cancer research, molecular biology, and molecular medicine. With a robust impact factor reflecting its significant influence—ranking in the Q2 category for cancer research and Q1 for both molecular biology and molecular medicine—it serves as an essential resource for scholars and practitioners alike. Since its inception in 1994, the journal has dedicated itself to advancing the understanding and therapeutic application of genetic innovations in oncology. Notably, it holds distinguished Scopus ranks, placing it among the top tier journals in its categories, underscoring its importance to the scientific community. While open access options are not available, the compelling research published here offers invaluable insights into the latest advancements and strategies in cancer therapy. Engaging with *Cancer Gene Therapy* not only keeps professionals informed but also inspires future innovations in the quest for effective cancer treatments.

Current Stem Cell Reports

Elevating Research Standards in Stem Cell Applications
Publisher: SPRINGER HEIDELBERGISSN: Frequency: 4 issues/year

Current Stem Cell Reports, published by Springer Heidelberg, is an esteemed academic journal that has emerged as a pivotal resource in the fields of Cell Biology, Developmental Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has consistently contributed to the evolving discourse on stem cell research and its applications, providing a platform for innovative studies and reviews through 2024. With a notable impact indicated by its quartile rankings—Q2 in Developmental Biology and Genetics, and Q3 in Cell Biology and Molecular Biology—it engages a diverse audience of researchers, professionals, and students who seek high-quality, accessible research insights. Although offering a traditional access model, the content remains vital for those invested in understanding the implications of stem cell advancements. Located in Switzerland and operating from the heart of Heidelberg, this journal aspires to bridge gaps in knowledge and stimulate collaboration in the burgeoning field of stem cell science.

Cell Stem Cell

Leading the Charge in Cellular Genetics and Molecular Medicine
Publisher: CELL PRESSISSN: 1934-5909Frequency: 12 issues/year

Cell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.

Stem Cell Research

Empowering the future of medical science.
Publisher: ELSEVIERISSN: 1873-5061Frequency: 6 issues/year

Stem Cell Research is a premier Open Access journal published by ELSEVIER, dedicated to advancing the understanding of stem cell biology. Since its inception in 2007, the journal has provided a platform for the latest research in the fields of Cell Biology, Developmental Biology, and Medicine, with its publication being accessible globally since 2014. Located in the Netherlands, the journal’s comprehensive scope aims to bridge fundamental discoveries with clinical applications, fostering collaboration among researchers and professionals. With a 2023 impact factor reflected in its Q4 ranking in Cell and Developmental Biology and a commendable position in the 64th percentile for General Medicine, Stem Cell Research remains a vital resource for those interested in the dynamic landscape of regenerative medicine. Targeting an audience that includes researchers, practitioners, and students, the journal emphasizes not only the significance of stem cells in medical science but also the ethical considerations and the public discourse surrounding stem cell research. Join the community committed to pioneering the future of stem cell science through rigorous peer-reviewed research.

Stem Cell Reviews and Reports

Bridging Knowledge Gaps in Cell Biology
Publisher: SPRINGERISSN: 2629-3269Frequency: 8 issues/year

Stem Cell Reviews and Reports is a prestigious journal published by SPRINGER specializing in the dynamic field of stem cell research, encompassing various aspects of cell biology and cancer research. With an ISSN of 2629-3269 and E-ISSN of 2629-3277, this journal serves as an essential resource for academics, offering insightful reviews and cutting-edge reports from 2009 to 2024. The journal has achieved a commendable Q2 ranking in both Cancer Research and Cell Biology categories as of 2023, highlighting its significant contribution to the scientific community. Additionally, with Scopus rankings placing it in the 74th percentile for both biochemistry and cell biology, it is recognized for its high-quality articles that foster innovative approaches in stem cell therapy and regenerative medicine. As an Open Access publication, Stem Cell Reviews and Reports ensures that its comprehensive content is readily available to researchers, professionals, and students, promoting collaboration and advancement in this vital area of study.

Cells

Empowering Researchers with Open Access to Breakthroughs
Publisher: MDPIISSN: Frequency: 24 issues/year

Cells, published by MDPI in Switzerland, is a leading open-access journal that has been disseminating groundbreaking research in the fields of Biochemistry, Genetics, and Molecular Biology since its inception in 2011. With an impressive E-ISSN of 2073-4409, the journal boasts a strong impact factor and ranks in the 84th percentile for Scopus ratings, underscoring its significance in advancing scientific knowledge. As a Q1-ranked journal in both 2023 and 2020, it serves as a premier platform for researchers, professionals, and students eager to explore innovative findings and methodologies. By providing unrestricted access to high-quality research, Cells plays a pivotal role in facilitating collaboration and inspiration within the global scientific community, making it an indispensable resource for anyone interested in cutting-edge discoveries in cellular biology.